is focused on antibody-based and antigen-based detection technologies, and on their application in lateral-flow immunoassay for both instrumented and visually-read tests.
The company holds substantial trade-secret-protected intellectual property—especially in production of unique,
high-sensitivity, concentrated gold sols and gold conjugates. The company holds a patent for its C-FLAT® lateral-flow test platform
Founders include leaders in the immunoassay field
and in related technologies.
The company has become the assay-development partner-of-choice for many established
players in the rapid-assay industry. Based on the demonstrable superiority of tests developed by BioAssay Works
the company's scientists have earned a world-class reputation.
BioAssay Works brings laboratory-based, ELISA
-like sensitivity to rapid-format, lateral-flow assays, while maintaining
field-use product durability and simplicity. The combination of proprietary nanoparticle technology
, patented assay platform,
and extensive assay-development experience enables the company to meet the objectives of its clients.